Table 2

Clinical Outcomes at 30 Days and 12 Months for All Patients (2.25- to 4.0-mm Stents)

Outcome30 Days (n = 1,398)12 Months (n = 1,376)
TLF1.4% (20)4.7% (65)
Death0.1% (1)1.3% (18)
 Cardiac0.1% (1)0.7% (9)
 Noncardiac0.0% (0)0.7% (9)
Myocardial Infarction1.2% (17)1.4% (19)
 Q-wave0.1% (1)0.1% (2)
 Non–Q-wave1.1% (16)1.2% (17)
Clinically-driven TLR0.1% (2)2.8% (39)
Clinically-driven TVR0.4% (5)4.6% (63)
Stent thrombosis (ARC definite + probable)0.1% (1)0.1% (2)
 Early (≤30 days)0.1% (1)0.1% (1)
 Late (>30 and ≤360 days)n/a0.1% (1)

Data are % (n).

 ARC = Academic Research Consortium; TLF = target lesion failure; TLR = target lesion revascularization; TVR = target vessel revascularization.

  • Probable stent thrombosis;

  • definite stent thrombosis.